AstraZeneca Gets CDSCO Nod For Cancer Drug

AstraZeneca Pharma Medical has received approval from India’s Central Drugs Standard Control Organisation (CDSCO) to import, market, and distribute trastuzumab deruxtecan. The approval covers an additional indication for the cancer treatment drug. The company announced this development in an official statement.